Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0600
+0.0010 (1.69%)
Aug 20, 2026, 1:28 PM AEST
Resonance Health Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 28 | 18 | 26 | 19 | 26 | 71 | |
Market Cap Growth | 39.06% | -32.02% | 36.13% | -25.00% | -63.87% | 7.38% |
Enterprise Value | 30 | 18 | 21 | 13 | 18 | 63 |
Last Close Price | 0.06 | 0.04 | 0.06 | 0.04 | 0.06 | 0.15 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 36.26 | - | 155.74 | - | - | 122.01 |
PS Ratio | 2.03 | 1.62 | 3.07 | 4.40 | 6.70 | 18.92 |
PB Ratio | 2.57 | 1.91 | 2.41 | 1.95 | 2.42 | 6.04 |
P/TBV Ratio | 6.89 | 7.47 | 7.18 | 1.95 | 2.42 | 6.04 |
P/FCF Ratio | 600.15 | 22.26 | 22.77 | - | - | 63.34 |
P/OCF Ratio | 66.94 | 14.36 | 19.01 | - | - | 60.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 2.13 | 1.63 | 2.42 | 2.99 | 4.75 | 16.79 |
EV/EBITDA Ratio | 21.30 | - | - | - | - | 151.50 |
EV/EBIT Ratio | 31.51 | - | - | - | - | 158.72 |
EV/FCF Ratio | 629.12 | 22.36 | 17.95 | - | - | 56.23 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.37 | 0.41 | 0.34 | 0.03 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 2.92 | - | - | - | - | 0.13 |
Debt / FCF Ratio | 86.34 | 4.72 | 3.19 | - | - | 0.05 |
Net Debt / Equity Ratio | 0.12 | 0.09 | -0.29 | -0.61 | -0.61 | -0.74 |
Net Debt / EBITDA Ratio | 1.21 | -0.59 | 7.71 | 4.61 | 4.37 | -21.00 |
Net Debt / FCF Ratio | 28.97 | 1.03 | -2.73 | 13.68 | 4.14 | -7.79 |
Asset Turnover | 0.77 | 0.58 | 0.55 | 0.39 | 0.32 | 0.33 |
Quick Ratio | 1.78 | 1.25 | 1.49 | 8.57 | 9.76 | 15.77 |
Current Ratio | 1.87 | 1.28 | 1.51 | 8.63 | 10.34 | 15.84 |
Return on Equity (ROE) | 7.33% | -17.05% | 1.62% | -7.57% | -10.14% | 5.39% |
Return on Assets (ROA) | 3.26% | -5.18% | -2.11% | -7.50% | -7.90% | 2.18% |
Return on Capital Employed (ROCE) | 6.50% | -12.50% | -3.70% | -13.50% | -14.00% | 3.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 2.73% | -9.67% | 0.64% | -4.03% | -4.42% | 0.82% |
FCF Yield | 0.17% | 4.49% | 4.39% | -2.30% | -6.10% | 1.58% |
Buyback Yield / Dilution | -5.65% | 2.81% | -1.59% | - | -1.97% | -4.59% |